amplifies the mitogenic effect of EGF in a rat liver through the adrenergic receptor coupled with G protein, Gh␣. Gh␣ is also known as a transglutaminase 2 (TG2), whose cross-linking activity is implicated in hepatocyte growth. Recently, we found that NE-induced amplification of EGF-induced DNA synthesis in hepatocytes obtained from perivenous regions of liver is caused by inhibiting the downregulation of EGF receptor (EGFR) by TG2. In the present study, we investigated the effect of aging on NE-related proliferative response. Hepatocytes were obtained from the liver of 7-and 90-wk-old rats. To examine this in detail, periportal hepatocytes (PPH) and perivenous hepatocytes (PVH) were isolated using the digitonin/collagenase perfusion technique. EGF or NE receptor binding was analyzed by Scatchard analysis. Changes in NE-induced DNA synthesis, G protein activity, and TG2 activity were measured. NE slightly potentiated [ 125 I]EGF binding to EGFR, and EGF-induced DNA synthesis in PVH but not in PPH.
A SIGNIFICANT DECREASE IN cell proliferation is a hallmark of aging in many cell lines (6, 14, 17, 34, 36) . A regeneration of rat liver is widely used as a model of aged cell proliferative capacity and responsiveness (5, 17) . The decline of DNA synthesis and loss of regeneration capacity are a typical phenomena associated with liver senescence. It has been shown that a faulty restoration of an aged liver is caused by a delayed cell cycle and a reduction of the number of proliferating hepatocytes (5, 49) . However, the mechanism by which aging causes impairment of the responsiveness of DNA synthesis to various growth factors and cytokines is still unclear. Hepatocytes are distinguished between periportal hepatocytes (PPH) and perivenous hepatocytes (PVH) on the basis of their metabolism and growth factor responsiveness (12, 32) . In particular, EGF and hepatocyte growth factor (HGF) both facilitate hepatocyte proliferation. (15) . Many studies have shown that EGF binds EGF receptors (EGFR) with two distinct affinities and subpopulations of EGFR (41) . Macdonald and Pike (24) recently provided the evidence that affinities of EGF binding to EGFR were regulated by negative cooperativity in an aggregating system. Moreover, the driving force for asymmetry in human EGFR dimmers may arise from the intracellular region in EGFR (21) . High-affinity EGFRs, which are correlated with Ras/MAPK and PI3K/Akt pathways (20) , are more highly expressed in periportal than in PVH, resulting in DNA synthesis correlating to the EGFR expression level (15) . We reported that age-related changes decreased the affinity of EGFR for EGF and attenuated EGFR dimerization in primary cultured hepatocytes (33) .
Transglutaminase 2 (TG2) is known as a multifunction enzyme. GTPase activity of TG2 acts as an ␣-subunit of Gh protein coupled with ␣ 1B -adrenergic receptor mediating the activation of PLC-␥1 (rather than the PLC-␤ family) and inositol phosphate production in response to adrenergic agonists such as epinephrine and phenylephrine. As a protein cross-linker, TG2 also catalyzes a calcium-dependent crosslinking reaction through the formation of ε-(␥-glutamyl) lysine isopeptide bonds. (2, 29, 51) . The GTP/GDP binding of TG2 has been shown to be involved in regulation of cell cycle progression. In contrast, the Ca 2ϩ -dependent cross-linking activity of TG2 contributes to the remodeling of the extracellular matrix and to the inhibition of cell growth (1, 50) . Additionally, Ca 2ϩ -activated TG2 interacts and modifies various intracellular and intranuclear proteins such as RhoA and pRB, respectively (30, 43) . These two distinct functions of TG2 are switched with the binding of either GTP or Ca 2ϩ to itself (10) . TG2 is more highly expressed in hepatocytes. Indeed, EGFR was modified by TG2, resulting in the restriction of dimerization and the autophosphorylation of EGFR in rat hepatocytes (25) .
Previous studies have shown that TG2 activity and its protein level in the both subpopulation of hepatocytes increases with aging (35) . These data suggests that the increased TG2 levels associated with aging in the liver might contribute to the deterioration of liver function.
Norepinephrine (NE) plays an important role both in adrenergic neurotransmission and in EGF-induced cell proliferation as an auxiliary factor in liver regeneration (13, 39) . NE amplified EGF-induced DNA synthesis mediating the ␣ 1 -adrenergic receptor in rat hepatocytes (8) . We revealed that NE induced a decrease in cross-linking activity of TG2 and an increase in inositol phosphate production, suggesting that NE treatment changed the function of TG2 (31) . Thus, the addition of NE appeared to restore EGF-induced DNA synthesis through abrogating this inhibitory modification of TG2 against EGFR in PVH.
The increased TG2 activity with aging may contribute to impaired DNA synthesis in response to EGF by means of inhibitory modification of EGFR by TG2 on primary cultured hepatocytes. These findings raise the possibility that NE may reverse the age-related decline in cell proliferative response to EGF through the regulation of TG2/Gh␣ function. In the present study, to examine this possibility, we investigated the effect of aging on NE-related proliferative response on primary cultured hepatocytes.
MATERIALS AND METHODS
Animals and materials. Male 7-and 90-wk-old Wistar rats (SLC, Hamamatsu, Japan) were kept at a controlled temperature (23 Ϯ 1°C) under a 12:12-h light-dark cycle and were maintained on a standard diet and water. All animal experiments were performed in strict accordance with our institutional animal committee's criteria for the care and use of laboratory animals. 3 H]radioreceptor assay kit were purchased from Perkin-Elmer Life Sciences (Boston, MA). Collagenase was obtained from Nitta Gelatin (Osaka, Japan). Digitonin and NE were obtained from Sigma-Aldrich (St. Louis, MO). Mouse EGF was obtained from Biomedical Technologies (Stoughton, MA). All other reagents were readily available commercial products of analytical grade and were used without further purification.
Isolation and culture of PPH and PVH. PPH and PVH subpopulations were isolated by using the digitonin/collagenase perfusion technique described by Quistorff (37) with modifications as described by Imai et al. (15) . The detailed procedure has been described previously (31) . After perfusion with collagenase solution, the liver lobes were carefully transferred to Hanks' buffer (Sigma-Aldrich, St. Louis, MO) and minced gently. The minced liver tissue was filtered through a 100-nylon mesh. After centrifugation at 50 g for 2 min, the supernatant was removed, and the cells were resuspended in Hanks' buffer and recentrifuged. After this procedure was repeated three times, the cells were suspended in William's E medium (SigmaAldrich, St. Louis, MO). Viability was determined by trypan blue staining and was found to be at a level of Ͼ 90% at this point. PPH and PVH were placed in 12-well collagen-coated plates (Iwaki, Tokyo, Japan) at a density of 0.8 ϫ 10 5 cells/cm 2 in William's E medium containing 10% FBS, 10 Ϫ9 M insulin, 10 Ϫ9 M dexamethasone, and 1% (vol/vol) antibiotics [penicillin G sodium (100 U/ml), streptomycin sulfate (100 g/ml), and amphotericin B (0.25 g/ml)] (GIBCO, Grand Island, NY). After 3 h incubation at 37°C in an atmosphere of 95% air and 5% CO2 at 100% relative humidity, the medium was replaced with serum-free medium.
Measurement of DNA synthesis. DNA synthesis was assessed by [methyl-
3 H]thymidine incorporation into hepatocytes. [Methyl-3 H]thymidine (0.5 Ci/ml) incorporation in PPH and PVH from 48 to 72 h was measured after treatment with or without 10 Ϫ8 M EGF, a concentration which induced the maximum proliferative effect, in the presence or absence of monodansylcadaverine (MDC). In the case of treatment with NE, the hepatocytes were treated 1 h before EGF treatment. After the incubation with or without EGF at 72 h, the cells were washed with PBS (pH 7.4), and solubilized in 1 M NaOH. Radioactivity of radiolabeled ligand bound to hepatocytes was measured using a gamma counter (Aloka ARC-370M; Tokyo, Japan). Nonspecific binding was determined in the presence of a 100-fold concentration of unlabeled ligand and amounted to less than 10% of the total binding.
Measurement of transglutaminase activity. Transglutaminase activity was assessed by [1,4- 14 C]putrescine incorporation into proteins of hepatocytes. In the case of treatment with NE, the hepatocytes were treated 1 h before EGF treatment. In the case of treatment with calcium chelator and NE, the hepatocytes were pretreated for 1 h with EGTA (2 mM) or BAPTA-AM (5 mM) before NE treatment. [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]putrescine was added at the time of EGF treatment in cultured hepatocytes. After 1-h incubation, hepatocytes were harvested with distilled water. The cell suspension was homogenized by a loosefitting Dounce homogenizer and was precipitated by 10% TCA. The precipitates were spotted onto Whatman 3MM filter paper, which was then immersed in 10% TCA solution. The radioactivity of each filter paper was measured using a Beckman LS6500 liquid scintillation counter.
Assay for phospholipase C activity. PLC activity was assessed by production of Ins(1,4,5)P 3 in hepatocytes using Ins(1,4,5)P3 [
3 H]radioreceptor assay kit. In the case of treatment with NE, the hepatocytes were treated 1 h before EGF treatment. Ins(1,4,5)P3 production in hepatocytes after EGF treatment was stopped at 1 h by adding ice-cold 20% TCA after removing the media as recommended by the manufacturer. The radioactivity was measured using a Beckman LS6500 liquid scintillation counter.
Statistical analysis. [1,4- 14 C]putrescine incorporation and production of Ins(1,4,5)P3.
Plasma membrane isolation and Western blot analysis. Plasma membranes from cultured hepatocytes were isolated by using the Percoll density gradient method. Cultured hepatocytes were homogenized in an ice-cold isolation medium containing 5 mM HEPES, 250 mM sucrose, and 1 mM EGTA supplemented with 1% protease inhibitor cocktail (Sigma-Aldrich) with 30 strokes on a loose-fitting Dounce homogenizer. The homogenates were then centrifuged at 600 g for 10 min, and the pellets were resuspended in isolation medium and Percoll was added (GE Healthcare) and centrifuged at 34,540 g for 30 min. A layer of plasma membrane fraction was washed with 50 mM Tris·HCl, pH 7.4. The isolated plasma membranes were subjected to Western blot analysis. The samples were mixed with SDS sample buffer containing 62.5 mM Tris·HCl buffer (pH 6.8), 10% glycerol, 2% SDS, and 5% mercaptoethanol and then were boiled and separated by SDS-PAGE.
The uptake of calcium chloride in PPH and PVH. Calcium chloride ( 45 Ca) was diluted to (370 kBq/ml) with saline, and 10 l added. After 4 h of incubation, culture medium was removed. The cells were washed with PBS twice and solubilized in NaOH. Radioactivity was measured by using a liquid scintillation counter (model LS-7800, Beckman).
RESULTS

Aging abolishes a potentiating effect of EGF-induced DNA synthesis through the adrenergic receptor in primary cultured PPH and PVH.
To examine the effect of aging on cell proliferative capacity, DNA syntheses in response to EGF combined with or without 1-h pretreatment of NE were assessed using [ 3 H]thymidine incorporation in rat primary cultured PPH and PVH derived from 7-and 90-wk-old rats (Fig. 1) . Consistent with other studies, primary cultured hepatocytes from 90-wk-old rats had lower responsiveness to EGF than those derived from 7-wk-old rats (33) . We previously reported that the stimulation of NE for 1 h only did not induce DNA synthesis but effectively recovered the number of high-affinity EGFRs in PVH from 7-wk-old rats (31) . Like the previous report, NE did not upregulate DNA synthesis without EGF on both PPH and PVH. Interestingly, NE was slightly effective in EGF-dependent DNA synthesis in PVH of 90-wk-old rats (Fig. 1B) .
Aging causes to decrease in high affinity EGFR for [ 125 I]EGF binding to primary cultured PPH and PVH. Our previous report
showed that NE 24-h stimulation led to an increase in the number of high-affinity EGFR in PVH from 7-wk-old rats by at least partially switching the function of TG2 from crosslinking to GTPase activity coupled with adrenergic receptors, resulting in the potentiation of DNA synthesis (31) . To investigate the effect of NE on affinity of EGFR with age, [
125 I]EGF binding assay was performed using primary cultured hepatocytes in 90-wk-old rats. Scatchard plots comparing [
125 I]EGF binding to EGFR in both subpopulations of hepatocytes derived from 7-and 90-wk-old rats are shown in Fig. 2 . The dissociation constants (K d ) and the number of binding sites (B max ) are described in Table 1 . EGF-dependent activation of the Ras/MAPK pathway is necessary for the high-affinity EGFR (20) . We showed that the lower responsiveness to EGF with aging resulted from the loss of high affinity of EGFR on hepatocytes (33) . As was expected, the high-affinity EGFR was downregulated and completely disappeared in both subpopulations in 90-wk-old rats (Fig. 2) . Although NE efficiently recovered the high affinity of EGFR and amplified EGFinduced DNA synthesis in PVH from 7-wk-old rats, it almost completely failed to restore the age-related decrease in highaffinity of EGFR on that from 90-wk-old rats (Fig. 2) . NE was able to slightly improve the affinity of impaired EGFR in PVH in 90-wk-old rats.
Effect of aging on [ 3 H]NE binding to primary cultured PPH and PVH in the presence of NE.
NE has been reported to enhance EGF-dependent DNA synthesis through the ␣ 1 -adrenergic receptor on rat hepatocytes (8) . In particular, ␣ 1B -adrenergic receptor has been shown to be mainly expressed on rat hepatocytes (48) . To investigate whether or not age-related changes caused a decrease in K d and/or B max values of NE binding to adrenergic receptors in rat hepatocytes, [ 3 H]NE binding assay was performed. We previously reported that in 7-wk-old rats, PVH were found to have a greater affinity and number of NE-binding receptors compared with PPH (31) . As was shown in another study (40) , adrenergic receptor populations displayed two different affinities for NE ( Fig. 3 and Table 2 ). PVH expressed a higher level of both high-affinity and lowaffinity ␣ 1 -adrenergic receptors than PPH in 90-wk-old as well as 7-wk-old rats. B max values of low-affinity receptors in both PPH and PVH obtained from 90-wk-old rats were increased to approximately twofold of that from 7-wk-old rats, respectively. These results show that age-related changes diminished the restoration of affinity of EGFR by NE treatment.
Effects of PLC activity in primary cultured PPH and PVH in the presence of NE. TG2 also acts as an ␣-subunit of Gh protein coupled with ␣ 1B -adrenergic receptor. NE exerts its action through the stimulation of phospholipase C-␦ 1 via ␣ 1B -adrenergic receptor/TG2 (Gh␣ protein). PLC catalyzes the hydrolysis of phosphatidylinositol 4,5-biphosphate to Ins(1,4,5)P 3 and diacylglycerol (2) . The impaired response to NE in aged rats may be caused by a functional alteration of adrenergic receptor signaling. To investigate the effect of aging on adrenergic receptor/TG2-mediated PLC-␦ 1 activation, a PLC activity assay was performed. In PPH, NE treatment exhibited almost no changes in PLC activity (Fig. 4) . The result reflected the low number of NE-binding receptors in PPH. On the other hand, Ins(1,4,5)P 3 production in PVH from 90-wkold rats decreased by half compared with 7-wk-old rats even though adrenergic receptors were expressed at high levels in PVH (Fig. 4B) . Thus, age-related changes may cause dysfunction of adrenergic receptor/Gh␣ pathway.
Effect of aging on TG2 activity in primary cultured PPH and PVH in the presence of NE. We previously reported that NE treatment for 1 h decreased cross-linking activity (enzymatic activity) of TG2 in PVH obtained from 7-wk-old rats (31) . Although the mechanism remains to be completely clarified, these data suggest that NE switches the function of TG2 from enzymatic activity to GTPase activity. This is because the binding of GTP/GDP to TG2 blocks its cross-linking activity. The protein expression and enzymatic activity of TG2 have been shown to increase with aging. Enhanced enzymatic activity of TG2 is implicated in age-related phenomena (19) . To investigate the effect of aging on TG2 function, we performed a [1,4- 14 C]putrescine incorporation assay to test cross-linking activity of TG2. Compared with 7-wk-old rats, the incorporation of [1,4- 14 C]putrescine into proteins enhanced significantly in both subpopulations in 90-wk-old rats (Fig. 5) . Addition of EGF had no effect on the incorporation of [1,4- 14 C]putrescine in the absence of NE in all subpopulations. Cross-linking activity in PVH was higher than that in PPH in 90-wk-old rats. As is the case with 7-wk-old rats, cross-linking activity was decreased by the addition of NE on both subpopulations obtained from 90-wk-old rats, while the rate of decrease in cross-linking activity in PVH from 90-wk-old rats was lower than from 7-wk-old rats (Fig. 5B) .
Although the number of NE receptors in rat hepatocytes increased with aging, the effect of NE on inhibition of enzy- Estimates of EGF binding affinities and numbers were calculated using GraphPad Prism 5.00. A Scatchard plot of the binding data showed a curvilinear relationship and yielded two apparent dissociation constants (Kd; in pM) of high-and low-affinity binding sites. Scatchard plots were shown in Figure 5 . Bmax, number of binding sites of EGFR (in pmol/3ϫ10 5 cells); high, high-affinity binding sites of adrenoceptor to EGF; low, low-affinity binding sites of adrenoceptor to EGF. matic activity weakened. This means that NE treatment in PVH from aged rats could not effectively switch the function of TG2 from enzymatic activity to GTP binding activity, unlike the case of 7-wk-old rats.
Intracellular location of TG2 in rat hepatocytes. The impaired responsiveness to NE in aged hepatocytes may imply loss of membrane-bound TG2. To investigate the subcellular distribution changes of TG2 with aging, compared with young rats, rat hepatocytes were fractionated on Percoll density gradient into membrane and cytosolic fractions.
TG2 in both membrane and cytosolic fractions appeared to slightly increase with aging (Fig. 6) . Estimates of NE binding affinities and numbers were calculated using GraphPad Prism 5.00. A Scatchard plot of the binding data showed a curvilinear relationship and yielded two apparent Kd (in pM) of high-and low-affinity binding sites. Scatchard plots were shown in Figure 2 . Effect of monodansylcadaverine on the DNA synthesis in PPH and PVH. The DNA synthesis in response to EGF in primary cultured hepatocytes was found to correlate negatively with aging (Fig. 1) . In particular, the DNA synthesis in hepatocytes from 90-wk-old rats had almost failed to respond to EGF treatment. To confirm whether or not age-related decline in cell proliferation in hepatocytes from 90-wk-old rats arose from crosslinking activity of TG2, the DNA synthesis was performed using MDC, a transglutaminase specific competitive inhibitor. As expected, MDC-pretreated cultured hepatocytes from 90-wk-old rats in response to EGF stimulation showed a moderate recovery from the age-related decline in DNA synthesis (Fig. 7) . Therefore, TG2 crosslinking activity was thought to be involved in the age-related decline in EGFinduced DNA synthesis in PPH and PVH. 45 Ca uptake of PPH and PVH from 7-and 90-wk-old rats. It has been reported that intracellular Ca 2ϩ concentration increases with aging (23, 44) . We measured the uptake of 45 Ca into PPH and PVH from 7-and 90-wk-old rats (Fig. 8) . There was no significant difference between PPH and PVH. Compared with 7-wk-old rats, both subpopulations from 90-wk-old rats had a higher uptake of 45 Ca.
Effect of Ca
2ϩ chelate on the crosslinking activity of TG2. Crosslinking activity of TG2 depends in large part on the presence of Ca 2ϩ . The influx of extracellular Ca 2ϩ might result in the increased crosslinking activity of TG2 in aged hepatocytes. Removing extracellular calcium with EGTA, a calcium chelator, suppressed remarkably TG2 crosslinking activity in both subpopulations (Fig. 9) . NE had no further inhibitory effect on TG2 activity in the present of EGTA. However, chelating intracellular calcium with BAPTA-AM, a membrane-permeable calcium chelator, partially inhibited crosslinking activity.
These results suggested that the influx of extracellular calcium was implicated in the control of proteins crosslinking activity of TG2 in PPH and PVH from 90-wk-old rats.
DISCUSSION
In the liver, age-related changes have been shown to include a reduction of liver mass and the dysfunction of protein M) for 1 h. Subsequently, TG2 cross-linking activity in hepatocytes was assessed by [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]putrescine incorporation into proteins of hepatocytes. The radioactivity of [1,4- 14 C]putrescine incorporated into proteins of cells was measured using a Beckman LS 6500 liquid scintillation counter. Each value represents the mean Ϯ SE of 3-4 independent experiments. *P Ͻ 0.05 and # P Ͻ 0.05 vs. the respective EGF-and NE-untreated groups. **P Ͻ0.05 vs. the respective 7-wk-old group by unpaired Student's t-test. synthesis and metabolism. Primary cultured hepatocytes from aged rats have been reported to show a decline in cell proliferative response to growth factors such as EGF and HGF (15) . Although the level of EGFR protein expression in hepatocytes in aged rats are similar to that in young adults, the EGFinduced autophosphorylation and dimerization of EGFR, and subsequent activation of Erk1/2 in aged rat hepatocytes is reduced, resulting in impaired DNA synthesis and delayed cell proliferation (33) . We showed that age-related loss of highaffinity of EGFR correlating with cell proliferation, despite no change in the number of total EGFR (Fig. 2) . TG2 activity has been shown to partially regulate the affinity of EGFR for EGF through its cross-linking modification (26) . Moreover, the expression level of TG2 protein is enhanced with aging in the rat liver. Considering these results, we speculate that the modification of EGFR by TG2, which has the substrate sequence for TG2 in its cytoplasmic domain, may contribute to the age-related decline in response of EGFR to EGF. We previously reported that NE could recover the affinity of EGFR for EGF in PVH where there were a lot of both TG2 and adrenergic receptors because of switching the function of TG2 from cross-linking activity to GTPase activity coupled with ␣ 1B -adrenergic receptor in 7-wkold rats (31) .
In the present study, we examined whether NE can restore the age-related impaired DNA synthesis in hepatocytes from 90-wk-old rats. The mRNA and protein expression of TG2 increases in liver (35) , especially in PVH, with age (unpublished data). Therefore, aging facilitated the TG2 activity and markedly decreased the number of high-affinity EGFR (33) . Surprisingly, the present data indicated that in 90-wk-old rats, NE treatment led to a slight increase in the affinity of EGFR to its ligand and in EGF-induced DNA synthesis in PVH, while NE-binding receptors increased (Figs. 2 and 3) . A possible reason for the lower proliferative response to NE may be alterations in expression of group of adrenergic receptors with subtypes (e.g., ␤ 1 -adrenergic receptor) on aged rat hepatocytes. In fact, it has been shown to be associated with age-related changes of expression pattern of adrenergic receptors in various organs such as liver (18, 22) .
As shown in Figs. 4 and 5, NE could not switch the TG2 function from protein cross-linking of activity to GTPase activity in aged rat liver. Aging augmented the expression and cross-linking activity of TG2 but not its GTPase activity (Figs.  4 and 5) . It has been reported that intracellular Ca 2ϩ concentration increases with aging (23). Shimokawa and Yamaguchi (42) reported a novel Ca 2ϩ binding protein regucalcin, which turned out to be identical with senescence marker protein-30 (SMP-30). Regucalcin/SMP-30 activates (Ca 2ϩ -Mg 2ϩ )-ATPase, which acts in the removal of Ca 2ϩ from the cytosol across the plasma membrane (45, 46) . This Regucalcin/ SMP-30 has been reported to decrease with aging in the rat liver (11, 16) . Considering our results, it is possible that TG2 cross-linking activity is maintained by high Ca 2ϩ concentration in aged liver.
Moreover, TG2 is found in various cellular localizations and is responsible for distinct cell functions. These facts raise the possibility that the difference of subcellular localization of TG2 between presenescence and senescence may effect the 45 Ca for 4 h. The uptake of 45 Ca into cells was measured by using a liquid scintillation counter. Each data represents the mean Ϯ SE of 3-4 independent experiments. *P Ͻ0.05 and # P Ͻ 0.05, compared with 7-with 90-wk-old groups by unpaired Student's t-test. Fig. 9 . Effect of Ca chelator on TG activity to PPH and PVH from 90-wk-old rats. PPH and PVH were pretreated with EGTA (2 mM) or BAPTA-AM (5 mM) for 1 h and were incubated with or without NE (10 Ϫ4 M) for 1 h. TG2 cross-linking activity were assessed by [1,4- 14 C]putrescine incorporation into proteins of hepatocytes as the same as Fig. 7. function of TG2 and, subsequently, various biochemical activities. Additionally, Citron et al. (7) have reported that intronexon swapping of TG2 mRNA in the brains of Alzheimer patients, which lack GDP/GTP binding domain, induced the increased cross-linking activity.
While TG2 variants in rodents have been previously unreported, a similar variant type of TG2 may contribute to the downregulation of high-affinity of EGFR in aged rat hepatocytes. TG2 is a multifunctional enzyme possessing crosslinking and GTPase activities. The cross-linking activity has been implicated in extracellular matrix organization and in inhibition of cell growth and proliferation (1, 50) . On the other hand, the GTPase function as G protein has been shown to be involved in regulation of cell cycle progression and receptormediated signaling. Increasing evidence has accumulated that TG-dependent protein cross-linking plays an important role in the pathologies of neurodegenerative diseases and aging. For example, increased TG2 activity appears to correlate with neurodegenerative diseases such as Alzheimer's disease and Huntington's disease (3, 27) . Moreover, Melino et al. (28) have reported that TG2 overexpression causes a dramatic reduction in proliferative capacity of human neuroblastoma cells. Therefore, our present data raise the possibility that the age-related decline in EGF-induced DNA synthesis of cultured hepatocytes is caused by augmented of TG2 activity.
Liver surgical resection is done to remove a hepatic carcinoma and to perform a live donor liver transplant. An insufficient regeneration of the liver causes a liver failure after surgery. It has been shown that the aging liver declines in its regenerative potential (5, 49) . Therefore, a number of investigators have been concerned about age-related decline in liver regenerative potential, as the number of aging patients and donor grows. An age-related decline in hepatocyte proliferative response results from high turnover of proliferation and decreased telomere length (47) and might be a risk factor for liver disorders such as hepatic cirrhosis and liver failure (38) . NE, which are released both from nerve endings and the adrenal gland into peripheral blood, enhance growth factorinduced hepatocyte proliferation after partial hepatectomy (9) . Our previous study also showed that NE augmented the mitogenic responsiveness to EGF in primary cultured hepatocytes from young adult rats by the switching of the function from TG2 to Gh␣ (31) . In this study, we showed that the high crosslinking activity of TG2 in aged rats was attributed, in part, to the elevated intracellular calcium level and decreased the sensitivity of EGFR to EGF, even in the presence of NE, unlike young adult rats.
Therefore, we think that the recovery of hepatic function including proliferative capacity is important for hepatic disease prevention. The present data provide useful information for further studies on age-related decline in proliferative response in the liver.
GRANTS
This study was in part supported by the Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Miyagi, Japan.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s). 
AUTHOR CONTRIBUTIONS
